There are 449 resources available
42P - Development of an online tool for the management of drug-drug interactions with the ROS1/TRK tyrosine kinase inhibitor repotrectinib
Presenter: David Burger
Session: Poster Display session
43P - Updated efficacy and circulating tumour (ct)DNA analysis in patients (pts) with TRK fusion lung cancer treated with larotrectinib (laro)
Presenter: Alexander Drilon
Session: Poster Display session
44P - Protecting supernatant cfRNA from cytology samples for the detection of fusions in advanced non-small cell lung cancer (NSCLC) patients
Presenter: Zheng Wang
Session: Poster Display session
45P - Actionable mutations in matched liquid and tissue biopsy next-generation sequencing
Presenter: Elaine Ko
Session: Poster Display session
46P - The frequency of driver mutations in non-small cell cancer patients: Analysis of the 5064 patients in the Turkish nation-wide, observational, registurkLung study
Presenter: Mahmut Yildirim
Session: Poster Display session
47P - Next-generation sequencing using tissue specimen collected with a 1.1 mm-diameter cryoprobe in patients with lung cancer
Presenter: Jung Seop Eom
Session: Poster Display session
48P - Real-world clinical utility of next-generation sequencing ctDNA for patients with advanced lung squamous cell carcinoma
Presenter: Miguel García Pardo de Santayana
Session: Poster Display session
49P - Perioperative circulating tumor DNA redefines induced oligometastatic non-small cell lung cancer at the molecular level
Presenter: Rui Fu
Session: Poster Display session
50P - Radiomic features of both primary lung nodules and lymph node metastases on chest CT associated with progression-free survival in advanced non-small cell lung cancer patients
Presenter: Mohammadhadi Khorrami
Session: Poster Display session
51P - Exploring the prognostic value of TP53 mutation in NSCLC in the era of precision oncology: A prospective real-world study
Presenter: Matthew Kin Liang Chiu
Session: Poster Display session